Dexamethasone induces caveolin-1 in vascular endothelial cells: implications for attenuated responses to VEGF

Biochemical markers for cardiovascular risk following treatment in endogenous Cushing’s syndrome

(2014) C. Kristo et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

A novel nucleic acid analogue shows strong angiogenic activity

(2010) Ikuko Tsukamoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Endothelial Dysfunction Aassociated with Hypercortisolism is Reversible in Cushing’s Syndrome

(2010) Itaru AKAZA et al.   ENDOCRINE JOURNAL

Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells

(2010) Shoshana Greenberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Paired Hormone Response Elements Predict Caveolin-1 as a Glucocorticoid Target Gene

(2010) Marinus F. van Batenburg et al.   PLoS One

Transforming growth factor-β1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells

(2009) Junsuke Igarashi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment

(2008) Cristiana Catena   ARCHIVES OF INTERNAL MEDICINE

Angiogenesis: A potentially critical part of remodelling in chronic airway diseases?

(2008) Eugene Haydn Walters et al.   PHARMACOLOGY & THERAPEUTICS

Vascular cell signaling by membrane estrogen receptors

(2008) K KIM et al.   STEROIDS

Caveolae as Organizers of Pharmacologically Relevant Signal Transduction Molecules

(2007) Hemal H. Patel et al.   Annual Review of Pharmacology and Toxicology

Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins

(2007) J Igarashi et al.   BRITISH JOURNAL OF PHARMACOLOGY